JP2019528247A5 - - Google Patents

Download PDF

Info

Publication number
JP2019528247A5
JP2019528247A5 JP2019501619A JP2019501619A JP2019528247A5 JP 2019528247 A5 JP2019528247 A5 JP 2019528247A5 JP 2019501619 A JP2019501619 A JP 2019501619A JP 2019501619 A JP2019501619 A JP 2019501619A JP 2019528247 A5 JP2019528247 A5 JP 2019528247A5
Authority
JP
Japan
Prior art keywords
methylquinoxalin
methoxy
thiazol
oxy
carbamate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019501619A
Other languages
English (en)
Japanese (ja)
Other versions
JP7058256B2 (ja
JP2019528247A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/041878 external-priority patent/WO2018013774A1/en
Publication of JP2019528247A publication Critical patent/JP2019528247A/ja
Publication of JP2019528247A5 publication Critical patent/JP2019528247A5/ja
Application granted granted Critical
Publication of JP7058256B2 publication Critical patent/JP7058256B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019501619A 2016-07-14 2017-07-13 二環式ヘテロアリール置換化合物 Active JP7058256B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662362113P 2016-07-14 2016-07-14
US62/362,113 2016-07-14
PCT/US2017/041878 WO2018013774A1 (en) 2016-07-14 2017-07-13 Bicyclic heteroaryl substituted compounds

Publications (3)

Publication Number Publication Date
JP2019528247A JP2019528247A (ja) 2019-10-10
JP2019528247A5 true JP2019528247A5 (https=) 2020-08-13
JP7058256B2 JP7058256B2 (ja) 2022-04-21

Family

ID=59384258

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019501619A Active JP7058256B2 (ja) 2016-07-14 2017-07-13 二環式ヘテロアリール置換化合物

Country Status (7)

Country Link
US (2) US20190292176A1 (https=)
EP (1) EP3484878B1 (https=)
JP (1) JP7058256B2 (https=)
KR (1) KR102460385B1 (https=)
CN (1) CN109689647B (https=)
ES (1) ES2823180T3 (https=)
WO (1) WO2018013774A1 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102494647B1 (ko) 2016-07-14 2023-01-31 브리스톨-마이어스 스큅 컴퍼니 비시클릭 헤테로아릴 치환된 화합물
US10815224B2 (en) 2016-07-14 2020-10-27 Bristol-Myers Squibb Company Monocyclic heteroaryl substituted compounds
CN109689664B (zh) 2016-07-14 2022-04-15 百时美施贵宝公司 作为par4抑制剂的三环杂芳基取代的喹啉和氮杂喹啉化合物
CN109836360B (zh) * 2019-03-19 2021-08-13 南京恩泰医药科技有限公司 一种甲苯磺酸依度沙班中间体的制备方法及中间体化合物
CN113024475B (zh) * 2019-12-25 2022-08-09 宁夏大学 一种喹喔啉酮类化合物的合成方法
CN111440146B (zh) * 2020-05-15 2022-10-21 中国药科大学 一种具有par4拮抗活性的苯并三嗪类化合物及其应用
JP7753950B2 (ja) * 2022-03-30 2025-10-15 三菱ケミカル株式会社 環状亜硫酸エステルの製造方法
US20260070871A1 (en) 2022-07-28 2026-03-12 Bayer Aktiengesellschaft Process for preparation of 2-chloro-3-fluoro-4-alkoxy-anilines and 2-fluoro-3-chlorophenol
JP2026504260A (ja) * 2022-12-22 2026-02-04 人福医薬集団股▲分▼公司 P2x3阻害剤を製造する方法
CN115925588A (zh) * 2022-12-26 2023-04-07 诚达药业股份有限公司 一种脂肪族亚磺酸钠盐的制备方法
AR131541A1 (es) 2023-01-07 2025-04-09 Syngenta Crop Protection Ag Compuestos de carboxamida novedosos
WO2025032129A1 (en) 2023-08-08 2025-02-13 Syngenta Crop Protection Ag Novel aminoindane and aminotetraline compounds
US11976055B1 (en) 2023-08-24 2024-05-07 King Faisal University 2-(1-(3-(dimethylamino)propyl)-4,5-diphenyl-1H-imidazol-2-yl)pyridin-3-ol as an antitumor and antimicrobial compound
US11986461B1 (en) 2023-08-24 2024-05-21 King Faisal University 3-(1-(3-(dimethylamino)propyl)-4,5-diphenyl-1H-imidazol-2-yl)pyridin-2-ol as an antitumor and antimicrobial compound
US11964959B1 (en) 2023-09-05 2024-04-23 King Faisal University 3-(4,5-Diphenyl-2-(pyridin-3-yl)-1H-imidazol-1-yl)-N,N-dimethylpopan-1-amine as an antimicrobial compound
WO2025109114A1 (en) 2023-11-24 2025-05-30 Syngenta Crop Protection Ag Novel carboxamide compounds
US11952361B1 (en) 2023-12-26 2024-04-09 King Faisal University 2-(1-(3-(dimethylamino)propyl)-4,5-diphenyl-1H-imidazol-2-yl) pyridin-3-ol as an antitumor and antimicrobial compound
PY2501648A (es) 2024-01-12 2025-10-31 Syngenta Crop Protection Ag Nuevos compuestos de carboxamida
WO2025149637A1 (en) 2024-01-12 2025-07-17 Syngenta Crop Protection Ag Novel carboxamide compounds
WO2026008750A1 (en) 2024-07-05 2026-01-08 Syngenta Crop Protection Ag Novel carboxamide compounds

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1164459A (en) * 1980-11-11 1984-03-27 Yung-Hsiung Yang Process for preparing (imidazo¬1,2-a|pyridine- 2-yl)-carbostyril or -3,4-dihydrocarbostyryl derivatives
SU1681729A3 (ru) * 1986-07-25 1991-09-30 Берингер Ингельгейм Кг (Фирма) Способ получени производных 1,4-бензодиазепина
TW279162B (https=) * 1991-09-26 1996-06-21 Mitsubishi Chem Corp
JP2928079B2 (ja) 1994-02-14 1999-07-28 永信薬品工業股▲ふん▼有限公司 1−(置換ベンジル)−3−(置換アリール)縮合ピラゾール類、その製造法及びその用途
US6166041A (en) 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
DE69723863T2 (de) * 1996-11-06 2004-04-15 Darwin Discovery Ltd., Slough Chinoline und deren therapeutische verwendung
US6313126B1 (en) * 1999-01-07 2001-11-06 American Home Products Corp Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression
US6387942B2 (en) 2000-06-19 2002-05-14 Yung Shin Pharmaceutical Ind. Co. Ltd Method of treating disorders related to protease-activated receptors-induced cell activation
EP1348701A1 (en) 2002-03-28 2003-10-01 Warner-Lambert Company LLC (2,4-disubstituted-thiazol-5-yl) amine compounds as PDE7 inhibitors
CA2534649A1 (en) 2003-08-01 2005-02-10 Genelabs Technologies, Inc. Bicyclic imidazol derivatives against flaviviridae
WO2005113522A1 (en) 2004-05-07 2005-12-01 Janssen Pharmaceutica, N.V. Azole carboxamide inhibitors of bacterial type iii protein secretion systems
RU2007107177A (ru) 2004-07-28 2008-09-10 Айрм Ллк (Bm) Соединения и композиции, как модуляторы ядерных рецепторов стероидных гормонов
ZA200705872B (en) 2005-01-14 2008-09-25 Genelabs Tecnologies Inc Indole derivatives for treating viral infections
WO2007149395A2 (en) 2006-06-20 2007-12-27 Amphora Discovery Corporation 2,5-substituted oxazole derivatives as protein kinase inhibitors for the treatment of cancer
RU2424233C2 (ru) 2006-06-29 2011-07-20 Ф.Хоффманн-Ля Рош Аг Производные бензимидазола, методы их получения, применение их в качестве агонистов фарнезоид-х-рецептора (fxr) и содержащие их фармацевтические препараты
WO2008073451A2 (en) 2006-12-11 2008-06-19 Sirtris Pharmaceuticals, Inc. Benzoimidazole derivatives as sirtuin (sir) modulating compounds
US20100305133A1 (en) 2007-11-30 2010-12-02 Smithkline Beecham Corporation Prolyl Hydroxylase Inhibitors
EA021938B1 (ru) 2008-05-01 2015-10-30 Сертрис Фармасьютикалз, Инк. Хинолины и их аналоги в качестве модуляторов сиртуина
GEP20125502B (en) 2008-05-23 2012-04-25 Novartis Ag Derivatives of quinolines and quinoxalines as protein tyrosine kinase inhibitors
AU2009274023A1 (en) 2008-07-23 2010-01-28 Vertex Pharmaceuticals Incorporated Tri-cyclic pyrazolopyridine kinase inhibitors
JPWO2010035745A1 (ja) * 2008-09-25 2012-02-23 杏林製薬株式会社 ヘテロ環ビアリール誘導体及びそれらを有効成分とするpde阻害剤
US20130072473A1 (en) 2011-05-09 2013-03-21 Proteostasis Therapeutics, Inc. Compounds for treating protein folding disorders
US9394297B2 (en) 2012-02-28 2016-07-19 Amgen Inc. Amides as pim inhibitors
BR112014026651A8 (pt) 2012-04-26 2018-01-16 Bristol Myers Squibb Co derivados de imidazotiadiazol e de imidazopiridazina como inibidores do receptor ativado por proteases 4 (par4) para o tratamento de agregação plaquetária
WO2013163244A1 (en) 2012-04-26 2013-10-31 Bristol-Myers Squibb Company Imidazothiadiazole derivatives as protease activated receptor 4 (par4) inhibitors for treating platelet aggregation
LT2841437T (lt) 2012-04-26 2017-09-11 Bristol-Myers Squibb Company Imidazotiadiazolo ir imidazopirazino dariniai, kaip proteazės aktyvuotų receptorių 4 (par4) inhibitoriai, skirti trombocitų agregacijos gydymui
US9617279B1 (en) 2014-06-24 2017-04-11 Bristol-Myers Squibb Company Imidazooxadiazole compounds
US9598419B1 (en) 2014-06-24 2017-03-21 Universite De Montreal Imidazotriazine and imidazodiazine compounds
ES2929208T3 (es) 2015-02-26 2022-11-25 Univ Montreal Compuestos de imidazotiadiazol como inhibidores de PAR4
EP3262052A1 (en) 2015-02-26 2018-01-03 Bristol-Myers Squibb Company Benzothiazole and benzothiophne compounds
JP2018515612A (ja) * 2015-05-13 2018-06-14 セルビタ スプウカ アクツィーナ 置換キノキサリン誘導体
JP2018525371A (ja) 2015-07-30 2018-09-06 ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company アリール置換された二環式ヘテロアリール化合物
US10815224B2 (en) 2016-07-14 2020-10-27 Bristol-Myers Squibb Company Monocyclic heteroaryl substituted compounds
CN109689664B (zh) 2016-07-14 2022-04-15 百时美施贵宝公司 作为par4抑制剂的三环杂芳基取代的喹啉和氮杂喹啉化合物
KR102494647B1 (ko) 2016-07-14 2023-01-31 브리스톨-마이어스 스큅 컴퍼니 비시클릭 헤테로아릴 치환된 화합물

Similar Documents

Publication Publication Date Title
JP2019528247A5 (https=)
JP7126541B2 (ja) ハンチントンタンパク質のイメージング用プローブ
CN104583218B (zh) 作为蛋白酶活化受体4(par4)抑制剂用于治疗血小板聚集的咪唑并噻二唑和咪唑并吡嗪的衍生物
KR102839394B1 (ko) 키나아제 억제제로서 헤테로시클릭 화합물, 헤테로시클릭 화합물을 포함하는 조성물 및 그 사용 방법
ES2823180T3 (es) Compuestos bicíclicos sustituidos con heteroarilo
CN111032656B (zh) 杂环化合物激酶抑制剂及其药物组合物和应用
JP7001682B2 (ja) 置換1H-イミダゾ[4,5-b]ピリジン-2(3H)-オン及びGLUN2B受容体調節因子としてのそれらの使用
JP2020527560A5 (https=)
RU2010134900A (ru) 5-фторпиримидиновые производные в качестве фунгицидов
JP2017526622A (ja) 3−アミノ−1,5,6,7−テトラヒドロ−4h−インドール−4−オン類
KR20170094263A (ko) Nadph 옥시다제 억제제인 아미도 티아디아졸 유도체
CA2897469A1 (en) Pyridine derivatives as muscarinic m1 receptor positive allosteric modulators
JP2019524732A5 (https=)
CN104125947A (zh) 杂环脲化合物
TW202434584A (zh) Gpr17調節劑及其用途
KR102390234B1 (ko) 트리시클릭 피페리딘 화합물
WO2012064269A1 (en) COMPOUNDS AND THEIR USE FOR TREATMENT OF Αβ-RELATED DISEASES
WO2009128661A2 (ko) 신규 벤조옥사진 벤즈이미다졸 유도체, 이를 포함하는 약학 조성물 및 이의 용도
AU2015212495A1 (en) Antibacterial combinations comprising polymyxin
WO2024095005A1 (en) Diaryl diazole and diaryl triazole derivatives for use in treating a disease associated with kcnk13 activity
WO2026035776A1 (en) Pi3k-alpha binding compounds and uses thereof
RU2025114402A (ru) Получение производных пиразолопиридина и триазолопиридина в качестве новых ингибиторов диацилглицерид о-ацилтрансферазы 2